Early prediction of intravenous corticosteroid therapy failure in moderate-severe ulcerative colitis

被引：0
|
作者：
Croft, A. [1 ]
Lord, A. [2 ]
Radford-Smith, G. [1 ]
机构：
[1] Royal Brisbane & Womens Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld, Australia
[2] QIMR Berghofer Med Res Inst, Gut Hlth Grp, Brisbane, Qld, Australia
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P536
引用
收藏
页码：S458 / S458
页数：1
相关论文
共 50 条
  • [21] UK guidance opens new therapeutic avenues for patients with moderate-severe ulcerative colitis
    Orchard, Tim
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (03) : 281 - 282
  • [22] Natural history of cytomegalovirus infection in a series of patients diagnosed with moderate-severe ulcerative colitis
    Criscuoli, Valeria
    Rizzuto, Maria Rosa
    Montallbano, Luigi
    Gallo, Elena
    Cottone, Mario
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (05) : 633 - 638
  • [23] Natural history of cytomegalovirus infection in a series of patients diagnosed with moderate-severe ulcerative colitis
    Valeria Criscuoli
    Maria Rosa Rizzuto
    Luigi Montalbano
    Elena Gallo
    Mario Cottone
    World Journal of Gastroenterology, 2011, 17 (05) : 633 - 638
  • [24] Ultrasonographic assessment of colonic wall in moderate-severe ulcerative colitis: Comparison with endoscopic findings
    Antonelli, Elisabetta
    Giuliano, Vittorio
    Casella, Giovanni
    Villanacci, Vincenzo
    Baldini, Vittorio
    Baldoni, Monia
    Morelli, Olivia
    Bassotti, Gabrio
    DIGESTIVE AND LIVER DISEASE, 2011, 43 (09) : 703 - 706
  • [25] Efficacy in biologic failure and non-biologic-failure populations in a Phase 3 study of ustekinumab in moderate-severe ulcerative colitis: UNIFI
    Sands, B. E.
    Peyrin-Biroulet, L.
    Marano, C.
    O'Brien, C. D.
    Zhang, H.
    Johanns, J.
    Szapary, P.
    Rowbotham, D.
    Leong, R. W.
    Arasaradnam, R. P.
    Danese, S.
    Van Assche, G.
    Targan, S.
    Sandborn, W. J.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S256 - S257
  • [26] EFFICACY IN BIOLOGIC-FAILURE AND NONBIOLOGIC-FAILURE POPULATIONS IN A PHASE 3 STUDY OF USTEKINUMAB IN MODERATE-SEVERE ULCERATIVE COLITIS: UNIFI
    Sands, Bruce E.
    Peyrin-Biroulet, Laurent
    Marano, Colleen W.
    O'Brien, Christopher D.
    Zhang, Hongyan
    Johanns, Jewel
    Szapary, Philippe
    Rowbotham, David
    Leong, Rupert W.
    Arasaradnam, Ramesh
    Danese, Silvio
    Van Assche, Gert A.
    Targan, Stephan R.
    Sandborn, William J.
    GASTROENTEROLOGY, 2019, 156 (06) : S181 - S182
  • [27] Infliximab trough levels are lower in patients with acute severe, compared to moderate-severe ulcerative colitis patients
    Ungar, B.
    Mazor, Y.
    Yanai, H.
    Ron, Y.
    Waizbard, A.
    Yavzori, M.
    Fudim, E.
    Picard, O.
    Loebstein, R.
    Kopylov, U.
    Dotan, I.
    Chowers, Y.
    Eliakim, R.
    Ben-Horin, S.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S314 - S315
  • [28] A personalised algorithm predicting the risk of intravenous corticosteroid failure in acute ulcerative colitis
    Croft, A.
    Okano, S.
    Hartel, G.
    Lord, A.
    Walker, G.
    Radford-Smith, G.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1382 - +
  • [29] A personalised algorithm predicting the risk of intravenous corticosteroid failure in acute ulcerative colitis
    Croft, Anthony
    Okano, Satomi
    Hartel, Gunter
    Lord, Anton
    Walker, Gareth
    Tambakis, George
    Radford-Smith, Graham
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (07) : 921 - 933
  • [30] Upadacitinib as rescue therapy for corticosteroid failure acute severe ulcerative colitis: an Asian experience from Taiwan
    Chung, Chen-Shuan
    Lee, Wei-Wei
    Le, Puo-Hsien
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2025, 40 (01)
12345